Literature DB >> 15955453

Chronic depletion of glutathione (GSH) and minimal modification of LDL in vivo: its prevention by glutathione mono ester (GME) therapy.

Namakkal Soorappan Rajasekaran1, Srinivasan Sathyanarayanan, Niranjali S Devaraj, Halagowder Devaraj.   

Abstract

A decline in reduced glutathione (GSH) level is associated with aging and free radical mediated diseases. The objective of this study was to determine whether the chronic depletion of extra cellular GSH causes oxidative damage to the circulating macromolecules such as lipoproteins. Decreased concentrations of plasma glutathione, vitamin E and ascorbic acid were recorded in the rats treated with buthionine sulfoximine (BSO), a selective GSH inhibitor. In LDL isolated from BSO-treated animals, the concentration of malondialdehyde (MDA) and conjugated dienes were significantly increased (P<0.01), whereas the levels of vitamin E were decreased (P<0.01). The analysis of total and LDL cholesterol revealed significant changes between the control and experimental groups. Of interest, altered concentrations of lyso-phosphatidyl choline (Lyso-PC) and phosphatidyl choline (PC) were recorded from the BSO mediated minimally modified LDL. A negative correlation between LDL-BDC/MDA and its antioxidant capacity was noted. Upon in vitro oxidation with CuSO(4), the electrophoretic behavior of purified LDL-apoprotein-B on agarose gel showed an increased mobility in BSO-treated rats, indicative of in vivo modification of LDL to become susceptible for in vitro oxidation. The increased mobility of LDL (after in vitro oxidation) isolated from the BSO-treated animals correlates with a decrease in its amino groups, as determined by the trinitrobenzene sulfonic acid (TNBS) reactants. However, the mobility of LDL molecule was not altered due to BSO treatment in vivo. Interestingly, the minimal modification on LDL does not lead to any vascular damage in the dorsal aorta of the rats injected with BSO. The administration of glutathione monoester (GME), at a dose of 5 mmol/kg body weight, twice a day, for 30 days, to animals treated with l-buthionine-SR-sulfoximine (BSO, 4 mmol/kg body weight, twice a day, for 30 days) normalized the antioxidant status and prevented the minimal modifications on LDL. Thus, increasing the cellular GSH levels may trigger beneficial effects against oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15955453     DOI: 10.1016/j.bbadis.2004.11.025

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

1.  Acute exercise stress activates Nrf2/ARE signaling and promotes antioxidant mechanisms in the myocardium.

Authors:  Vasanthi R Muthusamy; Sankaranarayanan Kannan; Kamal Sadhaasivam; Sellamuthu S Gounder; Christopher J Davidson; Christoph Boeheme; John R Hoidal; Li Wang; Namakkal Soorappan Rajasekaran
Journal:  Free Radic Biol Med       Date:  2011-10-20       Impact factor: 7.376

2.  Sustained activation of nuclear erythroid 2-related factor 2/antioxidant response element signaling promotes reductive stress in the human mutant protein aggregation cardiomyopathy in mice.

Authors:  Namakkal Soorappan Rajasekaran; Saradhadevi Varadharaj; Gayatri D Khanderao; Christopher J Davidson; Sankaranarayanan Kannan; Matthew A Firpo; Jay L Zweier; Ivor J Benjamin
Journal:  Antioxid Redox Signal       Date:  2011-02-02       Impact factor: 8.401

3.  Nrf2 deficiency prevents reductive stress-induced hypertrophic cardiomyopathy.

Authors:  Sankaranarayanan Kannan; Vasanthi R Muthusamy; Kevin J Whitehead; Li Wang; Aldrin V Gomes; Sheldon E Litwin; Thomas W Kensler; E Dale Abel; John R Hoidal; Namakkal S Rajasekaran
Journal:  Cardiovasc Res       Date:  2013-06-12       Impact factor: 10.787

4.  Maternal perinatal calorie restriction temporally regulates the hepatic autophagy and redox status in male rat.

Authors:  Asokan Devarajan; Namakkal S Rajasekaran; Claire Valburg; Ekambaram Ganapathy; Snehal Bindra; William A Freije
Journal:  Free Radic Biol Med       Date:  2018-09-21       Impact factor: 7.376

5.  Glutamine drives glutathione synthesis and contributes to radiation sensitivity of A549 and H460 lung cancer cell lines.

Authors:  Daniel R Sappington; Eric R Siegel; Gloria Hiatt; Abhishek Desai; Rosalind B Penney; Azemat Jamshidi-Parsian; Robert J Griffin; Gunnar Boysen
Journal:  Biochim Biophys Acta       Date:  2016-01-26

6.  Impaired transcriptional activity of Nrf2 in age-related myocardial oxidative stress is reversible by moderate exercise training.

Authors:  Sellamuthu S Gounder; Sankaranarayanan Kannan; Dinesh Devadoss; Corey J Miller; Kevin J Whitehead; Kevin S Whitehead; Shannon J Odelberg; Matthew A Firpo; Robert Paine; John R Hoidal; E Dale Abel; Namakkal S Rajasekaran
Journal:  PLoS One       Date:  2012-09-24       Impact factor: 3.240

7.  Protective Effects of Mogroside V on Oxidative Stress Induced by H2O2 in Skin Fibroblasts.

Authors:  Qiuting Mo; Hao Fu; Dan Zhao; Jiachan Zhang; Changtao Wang; Dongdong Wang; Meng Li
Journal:  Drug Des Devel Ther       Date:  2021-12-01       Impact factor: 4.162

8.  Intestinal barrier function in response to abundant or depleted mucosal glutathione in Salmonella-infected rats.

Authors:  Marleen T J van Ampting; Arjan J Schonewille; Carolien Vink; Robert Jan M Brummer; Roelof van der Meer; Ingeborg M J Bovee-Oudenhoven
Journal:  BMC Physiol       Date:  2009-04-17

9.  Reductive Stress Causes Pathological Cardiac Remodeling and Diastolic Dysfunction.

Authors:  Gobinath Shanmugam; Ding Wang; Sellamuthu S Gounder; Jolyn Fernandes; Silvio H Litovsky; Kevin Whitehead; Rajesh Kumar Radhakrishnan; Sarah Franklin; John R Hoidal; Thomas W Kensler; Louis Dell'Italia; Victor Darley-Usmar; E Dale Abel; Dean P Jones; Peipei Ping; Namakkal S Rajasekaran
Journal:  Antioxid Redox Signal       Date:  2020-06       Impact factor: 8.401

10.  An intracellular antioxidant determines the expression of a melanin-based signal in a bird.

Authors:  Ismael Galván; Carlos Alonso-Alvarez
Journal:  PLoS One       Date:  2008-10-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.